神经科学与罕见疾病发现和转化区(NRD DTA)正在开发治疗一系列严重神经疾病的药物,包括多发性硬化症、阿尔茨海默病、帕金森病、自闭症、脊髓性肌萎缩症和亨廷顿氏病。 As RiSE student in the NRD DTA you will join our group in Biomarkers and perform at the Roche Innovation Center Basel, Switzerland, where ...
With more than 7,000 employees, Roche China is now working to develop itself into Roche's third global strategic center after Basel and San Francisco, and making sustained efforts to fulfill its long-term commitment to China, so as to meet Chinese patients’ unmet needs. Roche is an Equal ...
My Skin Track UV and My UV Patch draw from partnership and research L’Oréal conducted in conjunction with Professor John Rogers from Northwestern University, through his portfolio of intellectual property and innovation around flexible, stretchable electronics and millimeter-scale wireless tech...
The deal, approved and recommended by Genentech's board, offers $95 for each outstanding Genentech Inc. share and ends a long corporate struggle between the Basel,Switzerland-based pharmaceutical giant and its cancer-drug partner. Roche Holding AG, which already owns 56 percent of the stock of ...
4058 BASEL Switzerland Museum Tinguely AG Museum Tinguely AG Paul-Sacher Anlage 2 4002 Basel Switzerland Phaor AG Phaor AG Grenzacherstrasse 124 4058 Basel Switzerland Roche Catalyst Investments AG Roche Catalyst Investments AG Grenzacherstrasse 124 ...
Princess Máxima Center for Pediatric Oncology, Utrecht, Principal lnvestigator of a research group (continued as advisor beyond 2022) 2019–2022 Roche Holding Ltd., Member of the Board of Directors Since 2022 Roche Basel, Head of Pharma Research and Early Development (pRED) ...
Roche 2023 results Basel, 1 February 2024 Group Thomas Schinecker Chief Executive Officer Performance Outlook 2023 guidance exceeded Group sales growth1 Guidance Low single digit decline Core EPS growth1 Broadly in line with sales decline Dividend outlook Further increase dividend in Swiss francs2 ...
With more than 7,000 employees, Roche China is now working to develop itself into Roche's third global strategic center after Basel and San Francisco, and making sustained efforts to fulfill its long-term commitment to China, so as to meet Chinese patients’ unmet needs. Roche is an Equal ...
Barbara Schaedler, Head of Group Communications and Member of the Enlarged CECBoris Zaïtra, Head of Corporate Business Development and Member of the Enlarged CECClaudia Böckstiegel, General Counsel and Member of the Enlarged CECLevi Garraway, Head of Global Product Development and CMO and ...
With more than 7,000 employees, Roche China is now working to develop itself into Roche's third global strategic center after Basel and San Francisco, and making sustained efforts to fulfill its long-term commitment to China, so as to meet Chinese patients’ unmet needs. Roche is an Equal ...